1,402 filings
ARS
2023 FY
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Apr 24
Annual report to shareholders
7:33pm
DEFA14A
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Apr 24
Additional proxy soliciting materials
7:32pm
8-K
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
19 Apr 24
Amendments to Articles of Incorporation or Bylaws
4:06pm
4
Davis Todd C
27 Mar 24
LIGAND PHARMACEUTICALS / Todd C Davis ownership change
5:47pm
4
ldgq8xdaxxxl8 bgye
7 Mar 24
LIGAND PHARMACEUTICALS / Stephen L Sabba ownership change
1:27pm
4
xnliwy2qa1un 9dfd
6 Mar 24
LIGAND PHARMACEUTICALS / Jason Aryeh ownership change
5:28pm
144
jmyocd
5 Mar 24
Notice of proposed sale of securities
6:12pm
S-8
5dqbt19lwkd1
1 Mar 24
Registration of securities for employees
4:09pm
4
4871iv4ic47zbrtiu
29 Feb 24
LIGAND PHARMACEUTICALS / Andrew Reardon ownership change
6:50pm
4
z107go 0ezw
29 Feb 24
LIGAND PHARMACEUTICALS / Matthew E Korenberg ownership change
6:50pm
4
m7ky681 gr
29 Feb 24
LIGAND PHARMACEUTICALS / Octavio Espinoza ownership change
6:50pm
4
0tn91nc 7rjco6e
29 Feb 24
LIGAND PHARMACEUTICALS / Todd C Davis ownership change
6:49pm
144/A
zuob0l3k
29 Feb 24
Notice of proposed sale of securities (amended)
4:49pm
144
7ede iwm3chhc1wsui
28 Feb 24
Notice of proposed sale of securities
6:05pm
144
li11ifdr3qhccmcak
28 Feb 24
Notice of proposed sale of securities
5:43pm
8-K
qxrjoq4 ro6j
27 Feb 24
Ligand Reports Fourth Quarter and Full Year 2023 Financial Results
7:24am
4
z2mnmc
16 Feb 24
LIGAND PHARMACEUTICALS / Andrew Reardon ownership change
8:10pm
4
ohyg aqnkbphi4gn07db
16 Feb 24
LIGAND PHARMACEUTICALS / Matthew E Korenberg ownership change
8:10pm